Multicentric Standardization of Protocols for the Diagnosis of Human Mitochondrial Respiratory Chain Defects.
diagnosis
enzyme activity
mitochondrial disease
mitochondrial respiratory chain
standardization
Journal
Antioxidants (Basel, Switzerland)
ISSN: 2076-3921
Titre abrégé: Antioxidants (Basel)
Pays: Switzerland
ID NLM: 101668981
Informations de publication
Date de publication:
08 Apr 2022
08 Apr 2022
Historique:
received:
02
02
2022
revised:
30
03
2022
accepted:
01
04
2022
entrez:
23
4
2022
pubmed:
24
4
2022
medline:
24
4
2022
Statut:
epublish
Résumé
The quantification of mitochondrial respiratory chain (MRC) enzymatic activities is essential for diagnosis of a wide range of mitochondrial diseases, ranging from inherited defects to secondary dysfunctions. MRC lesion is frequently linked to extended cell damage through the generation of proton leak or oxidative stress, threatening organ viability and patient health. However, the intrinsic challenge of a methodological setup and the high variability in measuring MRC enzymatic activities represents a major obstacle for comparative analysis amongst institutions. To improve experimental and statistical robustness, seven Spanish centers with extensive experience in mitochondrial research and diagnosis joined to standardize common protocols for spectrophotometric MRC enzymatic measurements using minimum amounts of sample. Herein, we present the detailed protocols, reference ranges, tips and troubleshooting methods for experimental and analytical setups in different sample preparations and tissues that will allow an international standardization of common protocols for the diagnosis of MRC defects. Methodological standardization is a crucial step to obtain comparable reference ranges and international standards for laboratory assays to set the path for further diagnosis and research in the field of mitochondrial diseases.
Identifiants
pubmed: 35453428
pii: antiox11040741
doi: 10.3390/antiox11040741
pmc: PMC9027926
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Instituto de Salud Carlos III
ID : PI17/00359
Organisme : Instituto de Salud Carlos III
ID : PI18/00498
Organisme : Instituto de Salud Carlos III
ID : PI18/00451
Organisme : Instituto de Salud Carlos III
ID : PI19/01772
Organisme : Instituto de Salud Carlos III
ID : PI21/00935
Organisme : Centre for Biomedical Network Research on Rare Diseases
ID : ISCIII-FEDER
Références
Nat Protoc. 2007;2(11):2719-27
pubmed: 18007607
Antioxidants (Basel). 2021 Nov 29;10(12):
pubmed: 34943024
Nature. 2012 Nov 15;491(7424):374-83
pubmed: 23151580
Methods. 2002 Apr;26(4):307-16
pubmed: 12054921
Clin Chim Acta. 1994 Jul;228(1):35-51
pubmed: 7955428
J Inherit Metab Dis. 2014 Jan;37(1):53-62
pubmed: 23774949
Scand J Rheumatol. 1999;28(5):319-23
pubmed: 10568430
Prog Mol Biol Transl Sci. 2014;127:93-131
pubmed: 25149215
Methods Cell Biol. 2001;65:1-35
pubmed: 11381588
Nat Protoc. 2012 May 31;7(6):1235-46
pubmed: 22653162
Mitochondrion. 2004 Sep;4(5-6):427-39
pubmed: 16120404
Bull Acad Natl Med. 2009 Jan;193(1):19-41; discussion 41-3
pubmed: 19718979
Anal Biochem. 2002 Dec 15;311(2):139-51
pubmed: 12470673
Mitochondrion. 2009 Sep;9(5):331-9
pubmed: 19439198
Methods Mol Biol. 2012;837:63-72
pubmed: 22215541
Nat Protoc. 2009;4(12):1790-7
pubmed: 20010930
J Clin Psychopharmacol. 2007 Jun;27(3):284-8
pubmed: 17502776
Mol Cell. 2008 Nov 21;32(4):529-39
pubmed: 19026783
Med Sci Monit. 2004 Sep;10(9):CS49-53
pubmed: 15328490
Mitochondrion. 2016 Nov;31:63-74
pubmed: 27771494
Antioxidants (Basel). 2021 Feb 20;10(2):
pubmed: 33672490
Biochem Biophys Res Commun. 2003 Jan 31;301(1):222-4
pubmed: 12535666
Methods Mol Biol. 2012;810:25-58
pubmed: 22057559